Structure–activity relationship study of novel iminothiadiazolo-pyrimidinone antimicrobial agents
Open Access
- 3 July 2013
- journal article
- research article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 66 (11) , 663-667
Abstract
An iminothiadiazolo-pyrimidinone derivative, 0002-04-KK, harboring a furan moiety, acts as an antimicrobial agent with a minimum inhibitory concentration (MIC) against Staphylococcus aureus of 25 μg ml−1. Several derivatives of 0002-04-KK were synthesized and among them 0026-59-KK, harboring a nitrofuran moiety, had the most potent antimicrobial activity with an MIC of 6 μg ml−1. Both 0002-04-KK and 0026-59-KK inhibited the biosynthesis of DNA, RNA and proteins. Peptidoglycan biosynthesis was inhibited by 0026-59-KK, and slightly inhibited by 0002-04-KK. Derivative 0002-04-KK showed bactericidal activity in contrast to the bacteriostatic activity of 0002-04-KK. Derivative 0002-04-KK had less toxicity in silkworms (lethal dose fifty (LD50): >230 μg g−1) than 0002-04-KK (LD50: 100 μg g−1). The bactericidal activity against S. aureus was because of the nitrofuran moiety. These findings suggest that iminothiadiazolo-pyrimidinone compounds could be used as lead molecules to develop antimicrobial agents.Keywords
This publication has 9 references indexed in Scilit:
- Identification of novel deoxyribofuranosyl indole antimicrobial agentsThe Journal of Antibiotics, 2011
- Reduced Vancomycin Susceptibility inStaphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical ImplicationsClinical Microbiology Reviews, 2010
- Waves of resistance: Staphylococcus aureus in the antibiotic eraNature Reviews Microbiology, 2009
- MDR-TB and XDR-TB: drug resistance and treatment outcomes: Table 1—European Respiratory Journal, 2009
- Silkworm as a model animal to evaluate drug candidate toxicity and metabolismComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2009
- Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 2008
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988
- "Celbenin" - resistant StaphylococciBMJ, 1961